Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea.

By Y. Kaneko, J. Floras, K. Usui, J. Plante, R. Tkacova, T. Kubo, S. Ando, T. Bradley. New England Journal of Medicine, 2003

1,065 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Physiology

View Paper: https://www.semanticscholar.org/paper/47d7a32a309b0c6ea6b5b97a5240ac4ab2e3c3f7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Physiology

Citations in the corpus

Sleep‐disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients (2007, background): “With respect to cardiac function, OSAmight be a cause of daytime systolic LVdysfunction,whichmay resolve following effective continuous positive airway pressure (CPAP) therapy [26–30].”
Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. (2004, methodology): “A recently published randomized controlled trial by Kaneko and coworkers demonstrated a significant improvement in cardiac function associated with a fall in systemic blood pressure with 1 month CPAP in patients with idiopathic and ischemic cardiomyopathy ( 20 ).”
Risk factors for obstructive sleep apnea in adults. (2004, background): “Of major clinical importance is the recent observation that in patients with congestive heart failure, treatment of OSA for 1 month was associated with an increase in ejection fraction and decreases in systolic blood pressure and heart rate.(35) These findings raise the question of whether routine s”
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “Smaller studies suggest that continuous positive airway pressure can improve cardiac function, sympathetic activity, and HRQOL in patients with HF and obstructive sleep apnea.(395,396)”
Pathophysiology of sleep apnea. (2010, background): “In patients with systolic dysfunction and moderate to severe OSA, CPAP treatment improved ejection fraction, functional status, and quality of life (293, 387).”
Obstructive sleep apnea: implications for cardiac and vascular disease. (2003, background): “In small groups of patients with heart failure and OSA, there was modest improvement in both ejection fraction and functional class after treatment with CPAP.113,131,132 Withdrawal of treatment in some of these patients resulted in a deterioration in both of thesemeasurements.”
Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun (2008, background): “Similarly, another study showed that mortality in OSA patients with an AHI 20 was 0% over 8 years in those treated with tracheostomy or nasal CPAP, significantly lower than those treated with uvulopalatopharyngoplasty or those left untreated.62 Population-based longitudinal studies with objective me”
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “Smaller studies suggest that continuous positive airway pressure can improve cardiac function, sympathetic activity, and HRQOL in patients with HF and obstructive sleep apnea (395,396).”